Skip to main content
SpringerLink
Log in

Investigations continue into Pandemrix-narcolepsy link

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. EMA.Pharmacovigilance Risk Assessment Committee (PRAC) Minutes of meeting 3-5 September 2012. World Wide Web [online]: [24 pages], 5 Oct 2012. Available from: URL: http://www.ema.europa.eu

  2. Etude NarcoFlu-VF (NarcoFlu VAESCO-France): Grippe, Vaccination Antigrippale et Narcolepsie: contribution francaise a l'etude cas-temoins europeene. Internet Document: [54 pages], 6 Aug 2012. Available from: URL: http://ansm.sante.fr

  3. European Centre for Disease Prevention and Control.Narcolepsy in association with pandemic influenza vaccination - A multi-country European epidemiological investigation. Internet Document: [164 pages], 29 Oct 2012. Available from: URL: http://www.ecdc.europa.eu

  4. EMA.European Medicines Agency reviews hypothesis on Pandemrix and development of narcolepsy. Media Release: 19 Oct 2012. Available from: URL: http://www.ema.europa.eu

Download references

Additional information

Key words

Pharmacovigilance; adverse reactions; Influenza-A-virus-vaccine-H1N1; Children; drug-induced; Adolescents; Narcolepsy

Rights and permissions

Reprints and permissions

About this article

Cite this article

Investigations continue into Pandemrix-narcolepsy link. React. Wkly. 1426, 2 (2012). https://doi.org/10.2165/00128415-201214260-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214260-00003

Keywords

Search

Navigation